Delmarva Health thru CBD

02/13/2026

From the mid-1800s until the 1930s, cannab*s was not controversial in American medicine. It was mainstream.

Archived medical records show that cannab*s extracts were listed in the United States Pharmacopeia, the official reference used by doctors and pharmacists. Physicians prescribed it for pain, muscle spasms, sleep problems, digestive issues, migraines, inflammation, and nervous system disorders.

According to historical pharmacy journals and medical textbooks of the era, over 100 illnesses and conditions were treated with cannab*s-based medicines. These products were manufactured by major pharmaceutical companies and sold legally in pharmacies across the country.

This medical use did not disappear because of new scientific evidence against it. Instead, policy changes in the 1930s gradually removed cannab*s from medical practice, reshaping public perception for decades.

Today, researchers are revisiting historical records to understand how a once-common medicine became a forgotten chapter in American healthcare.

➡️ Note: This content is shared for academic interest, based on scientific studies and historical records. It does not promote, sell, or encourage recreational or non-medical substance use.

02/08/2026

According to a study, published in the journal, Advances in Experimental Medicine and Biology, TRPV receptors may be the key to killing cancer with cannabis.

More importantly, a healthy TRPV system may prevent us from developing cancer in the first place!

READ MORE ABOUT THE TRPV: https://rxleaf.com/trpv1-the-receptor-thats-coming-for-endometrial-cancer/

02/07/2026

The Godfather of cannabis research...

Dr. Raphael Mechoulam, often called the pioneer of modern cannabis science, helped uncover how cannabis compounds interact with the human body. His research led to the identification of THC and opened the door to discovering the endocannabinoid system, a widespread network of receptors and signaling molecules found throughout the brain and immune system.
This system plays a major role in regulating essential functions such as pain perception, mood, appetite, memory, stress response, and inflammation balance. Mechoulam’s discoveries transformed cannabis from a misunderstood plant into a key scientific pathway for understanding one of the body’s most important biological control systems, with lasting implications for medicine and neuroscience.



Mechoulam, R., & Gaoni, Y. (1965). A total synthesis of dl-Δ1-tetrahydrocannabinol, the active constituent of hashish. Journal of the American Chemical Society, 87(14), 3273–3275.

Di Marzo, V., & Piscitelli, F. (2015). The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics, 12(4), 692–698.

02/04/2026

𝗙𝗿𝗼𝗺 𝘁𝗵𝗲 𝗘𝗻𝗱𝗼𝗰𝗮𝗻𝗻𝗮𝗯𝗶𝗻𝗼𝗶𝗱 𝗦𝘆𝘀𝘁𝗲𝗺 → 𝘁𝗼 𝘁𝗵𝗲 𝗘𝗻𝗱𝗼𝗰𝗮𝗻𝗻𝗮𝗯𝗶𝗻𝗼𝗶𝗱𝗼𝗺𝗲

Healing isn’t controlled by a single switch.
It’s an ecosystem.

Science is expanding our understanding beyond the Endocannabinoid System (ECS) to what researchers now call the *endocannabinoidome* — a vast, interconnected network linking mood, immunity, gut health, inflammation, metabolism, and neuroplasticity.

This means emotional wellness, connection, and even love aren’t happening in just one place in the body…
They emerge from many systems working together in harmony.

Your brain.
Your gut.
Your immune system.
Your nervous system.
All in conversation. Always.

When we support the whole body, we support the whole person. 🌿

Want to explore how connection, biology, and the endocannabinoid system shape well-being? We dive deeper in our latest blog.

🔗 Links in the comments

02/02/2026

Most patients are told cannabis is “mild” when it comes to inflammation. The research says otherwise.

A study titled "Anti-inflammatory Activity of Cannabinoids in Carrageenan-Induced Paw Edema in the Rat" published in 1987, compared delta-9 THC against common anti-inflammatory agents. The results surprised even the researchers. THC showed anti-inflammatory potency roughly 20 times that of aspirin and about 2 times that of hydrocortisone in that model.

That matters more than most realize.

Aspirin and corticosteroids work by aggressively blocking inflammatory pathways. They shut things down fast, but they also come with tradeoffs when used long-term. THC worked differently. It reduced inflammation while interacting with regulatory systems that control immune responses, pain signaling, and tissue repair.

This is where the ECS, our Master Regulator, becomes impossible to ignore.

THC does not just blunt inflammation. It modulates it. It signals through cannabinoid receptors that help the body decide how much inflammation is appropriate and when to stand down. That distinction explains why some patients experience relief without the rebound flare-ups common with steroids and NSAIDs.

This does not mean THC replaces aspirin or hydrocortisone in every situation. Acute trauma and autoimmune crises still require conventional tools. What it does mean is that cannabis was never a weak medicine. It was misunderstood medicine.

When inflammation is chronic, driven by stress, injury, or dysregulated immune signaling, force is rarely the best answer. Coordination is. Cannabinoids excel there because they speak the body’s native language instead of overriding it.

This is also why THC performs better when paired with other cannabinoids like CBGa and CBDa. Together, they reduce the inflammatory load, support endocannabinoid tone, and help the system resolve rather than suppress.

Calling cannabis “alternative” ignores decades of pharmacological data.

The research has been telling the same story for a long time. THC is not soft. It is strategic. And when inflammation is the real enemy, that difference changes outcomes.

-Mike Robinson, The Researcher OG

01/30/2026

Before 1937, cannabis tinctures were not fringe medicine or counterculture remedies. They were mainstream pharmaceuticals, used daily by physicians to treat arthritis pain, inflammation, sleep disruption, and, at the time, what doctors called rheumatic disease.

In the late 1800s and early 1900s, cannabis tinctures were listed in the United States Pharmacopeia and the British Pharmacopeia. That matters because inclusion meant standardized preparation, dosing guidance, and accepted medical use. These tinctures were alcohol-based extracts of the cannabis plant, designed for oral use, easy absorption, and consistent effects. Doctors trusted them because they worked and because they were gentler on the stomach than many other options available at the time.

Arthritis patients were among the most common recipients. Long before we understood the ECS, our Master Regulator, clinicians observed that cannabis tinctures reduced joint pain, stiffness, and swelling while also improving sleep. That combination mattered. Pain relief without heavy sedation and improved rest without respiratory suppression were rare in that era.

Major pharmaceutical companies openly sold these products. Eli Lilly, Parke-Davis, Squibb, and Merck all produced cannabis-based medicines. These were not homemade remedies. They were labeled, dosed, and prescribed. Sir William Osler, often called the father of modern medicine, referenced cannabis preparations as effective for pain and muscle spasm. This was clinical observation guiding practice, not ideology.

What made tinctures especially effective for arthritis was their systemic action. When taken orally, cannabinoids circulate throughout the body, interacting with inflammatory pathways, nervous system signaling, and immune tone. Today, we will explain this through endocannabinoid signaling, cytokine modulation, and neural feedback loops. Back then, doctors simply noted that patients moved better, slept longer, and relied less on opiates.

All of that changed in 1937.

The Ma*****na Tax Act did not ban cannabis outright, but it made medical use legally dangerous and financially impossible. Doctors faced paperwork, scrutiny, and criminal risk. Pharmaceutical companies walked away. Within a few years, cannabis was removed from the Pharmacopeia, not because it failed patients, but because politics replaced medicine.

Arthritis care shifted toward aspirin, then steroids, then synthetic anti-inflammatories, and eventually long-term opioid use. Each step moved further away from whole-system balance and closer to symptom suppression.

When we talk today about rediscovering cannabis tinctures for arthritis, this is not new medicine. It is a restorative medicine. The plant never stopped working. We simply stopped listening to the patients who were already getting relief.

-Mike Robinson, The Researcher OG

01/27/2026

Here’s the truth most miss when they talk about cannabinoids. The ECS, our Master Regulator, responds to inputs all day long, and diet and exercise are not optional side notes; they are the foundation. Cannabinoids work best when the system they interact with is properly fed, moved, and supported.

Food is information. Every fat, fiber, and micronutrient you consume tells the ECS how to behave. Omega-3 fats help form endocannabinoids like anandamide and 2-AG, while highly processed foods push the system toward inflammation and receptor desensitization. When the diet is poor, cannabinoids have less to work with. When the diet is dialed in, cannabinoids amplify what the body is already doing naturally.

Movement is just as critical. Exercise is one of the most powerful ways to stimulate endocannabinoid production. This is not theory; it is measurable biology. When someone moves their body with intention, endocannabinoids rise, receptors become more responsive, and signaling improves across the nervous, immune, and metabolic systems. This is why cannabinoids feel different in an active body versus a sedentary one.

Now layer in the right cannabinoids for the right need. Someone dealing with inflammation and fatigue may respond better to acidic or minor cannabinoids that support balance without overstimulation. Someone struggling with appetite, pain, or sleep may need a different profile entirely. There is no universal cannabinoid solution, only context-driven use.

This is where most get it wrong. They chase a compound instead of building a system. Diet feeds the ECS. Exercise activates it. Cannabinoids guide it. When those three work together, balance becomes sustainable, not forced.

Research continues to confirm this relationship, including the study “Exercise-induced endocannabinoid signaling is modulated by intensity,” 2012, which showed physical activity directly increases circulating endocannabinoids. That is the blueprint. Build the body first, then let cannabinoids do what they do best.

Reach out for guidance.

-Mike Robinson, The Researcher OG

01/24/2026

I have found that CBN is the best cannabinoid for sleep.

Additional improvements in overall health-related quality of life

01/19/2026

A landmark clinical trial published in the European Heart Journal in late 2025 has confirmed that chronic CBD supplementation significantly reduces both systolic and diastolic blood pressure in patients with primary hypertension.

Conducting research at the University of Split in Croatia, scientists monitored 70 patients over a five-week period in a rigorous triple-blind study. Unlike the placebo group, those receiving a daily CBD regimen—ranging from 225 mg to 450 mg depending on weight—experienced a consistent drop of approximately 4 mmHg in systolic and 3 mmHg in diastolic blood pressure. This discovery moves CBD from a "stress reliever" to a legitimate cardiovascular tool, proving that long-term use can help stabilize the body's internal pressure systems without the harsh side effects often associated with traditional diuretics.

The neuroscience behind this drop is fascinating—CBD appears to lower blood pressure by modulating the sympathetic nervous system and reducing levels of urotensin-II and catestatin, markers linked to vascular stress. By relaxing the walls of the blood vessels and improving "endothelial function," CBD allows blood to flow more freely, reducing the strain on the heart muscle. This finding aligns with a massive analysis of over 91,000 adults published in Nature: Scientific Reports, which linked lifetime cannabis use to lower baseline blood pressure, suggesting a deep-rooted biological connection between cannabinoids and heart health.

As we look toward 2026, this study provides a clear path for using medical cannabis as a specialized adjunctive therapy for hypertension, especially in patients who struggle with standard medication. While researchers emphasize that CBD should complement—not replace—healthy lifestyle changes, the evidence is undeniable: the "rest and digest" properties of CBD are a powerful ally for a stressed cardiovascular system. We are finally seeing a major shift in heart medicine, where natural compounds are being validated by the world's most prestigious medical journals as a safe, chronic solution for hypertension.

Would you feel more confident managing your heart health if your doctor prescribed a natural CBD supplement alongside traditional treatments?

09/23/2025

Going Out of Business – Thank You for Everything

It is with heavy hearts that we announce we will be closing our doors.

We want to sincerely thank all of our customers, friends, and community who have supported us throughout the years. Your trust, encouragement, and belief in what we do has meant the world to us.

As a final thank you, we are offering 25% off all products until everything is gone. This is your last chance to stock up on your favorites before we say goodbye. Minimum 2 item purchase.

From the bottom of our hearts, thank you for being part of our journey.

— Delmarva Health thru CBD

08/13/2025

I love CBGa because it treats balance like a job, not a slogan. The Master Regulator needs raw materials and clear signals, and CBGa shows up early, works quietly, and sets the tone for everything that follows. It is the mother molecule in the plant, a starting point that the body seems to understand.

When I stack it into a protocol, I see steadier mornings, calmer afternoons, and a nervous system that is less jumpy and more coachable.

I love it because it plays nicely with others. CBGa pairs with magnesium, omega-3s, B-vitamins, and a sane sleep schedule, then nudges our own endocannabinoids to stick around longer. That means less noise in the background, fewer false alarms, and more room for real relief.

Heavy THC users tell me their tolerance softens when CBGa is in the mix, receptors feel reachable again, and the plant works like it should instead of shouting to be heard.

I love it because it is clear-headed. People can function, think, and still feel that quiet support under the hood. Morning CBGa with coffee, after water and electrolytes is my baseline, then I adjust the rest based on the day's schedule and the body's needs.

I love it because the outcomes keep lining up with the biology. Better tone in the stress response, smoother gut days, fewer flare signals in joints and skin, and a mind that does not flood every time life throws a curve.

I have watched this across years, in complex cases and simple ones, and the pattern holds. You can start with balance by lowering tolerance with CBGa, protecting your own endocannabinoid tone and signals, and then let the rest of the plan do its work.

That is why I keep saying it. CBGa first, not as a fad, as a foundation. Get your habits right, keep your hydration tight, listen to your body, and let The Master Regulator do what it does best.

-Mike Robinson, The Researcher OG